Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Katz

Showing results (651-660 of 749) with videos related to

Pageof 75
Sort By:
Annals of Surgery|March 20, 2024
Trends Over Time in Recurrence Patterns and Survival Outcomes after Neoadjuvant Therapy and Surgery for Pancreatic CancerSamuel H Cass, Ching-Wei D Tzeng, Laura R Prakash, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|October 17, 2013
Radiographic tumor-vein interface as a predictor of intraoperative, pathologic, and oncologic outcomes in resectable and borderline resectable pancreatic cancerHop S Tran Cao, Alpana Balachandran, Huamin Wang, et al.
Annals of Surgical Oncology|December 19, 2014
Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic CancerAmanda B Cooper, Rebecca Slack, David Fogelman, et al.
Surgery Open Science|June 24, 2022
Risk-stratified posthepatectomy pathways based upon the Kawaguchi-Gayet complexity classification and impact on length of stayBradford J Kim, Elsa M Arvide, Cameron Gaskill, et al.
Surgical Oncology|September 24, 2023
Elevated CA 19-9 is associated with worse survival in patients with resected ampullary adenocarcinomaArtem Boyev, Laura R Prakash, Yi-Ju Chiang, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|January 13, 2022
Iterative Changes in Risk-Stratified Pancreatectomy Clinical Pathways and Accelerated Discharge After PancreaticoduodenectomyAndrew D Newton, Timothy E Newhook, Morgan L Bruno, et al.
BMC Cancer|July 29, 2017
Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreasMatthew H G Katz, Fang-Shu Ou, Joseph M Herman, et al.
Current Oncology (Toronto, Ont.)|February 26, 2026
Primary Tumor Size and Tumor-Vessel Interface Following Capecitabine and Temozolomide for Pancreatic Neuroendocrine TumorJin Guo, Kever A Lewis, Laura Prakash, et al.
JAMA Surgery|April 15, 2026
An American College of Surgeons National Quality Improvement Collaborative to Enhance Lung Cancer Surgical QualityKelley Chan, Eileen M Reilly, Ryan C Jacobs, et al.
Journal of the National Cancer Institute|May 11, 2026
Prediction of resection after preoperative FOLFIRINOX in patients with localized pancreatic adenocarcinoma: a Trans-Atlantic Pancreatic Surgery (TAPS) Consortium studyE M M Verkolf, J L van Dam, E N Dekker, et al.
Pageof 75

Showing results (651-660 of 749) with videos related to

Sort By:
Pageof 75
Annals of Surgery|March 20, 2024
Trends Over Time in Recurrence Patterns and Survival Outcomes after Neoadjuvant Therapy and Surgery for Pancreatic CancerSamuel H Cass, Ching-Wei D Tzeng, Laura R Prakash, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|October 17, 2013
Radiographic tumor-vein interface as a predictor of intraoperative, pathologic, and oncologic outcomes in resectable and borderline resectable pancreatic cancerHop S Tran Cao, Alpana Balachandran, Huamin Wang, et al.
Annals of Surgical Oncology|December 19, 2014
Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic CancerAmanda B Cooper, Rebecca Slack, David Fogelman, et al.
Surgery Open Science|June 24, 2022
Risk-stratified posthepatectomy pathways based upon the Kawaguchi-Gayet complexity classification and impact on length of stayBradford J Kim, Elsa M Arvide, Cameron Gaskill, et al.
Surgical Oncology|September 24, 2023
Elevated CA 19-9 is associated with worse survival in patients with resected ampullary adenocarcinomaArtem Boyev, Laura R Prakash, Yi-Ju Chiang, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|January 13, 2022
Iterative Changes in Risk-Stratified Pancreatectomy Clinical Pathways and Accelerated Discharge After PancreaticoduodenectomyAndrew D Newton, Timothy E Newhook, Morgan L Bruno, et al.
BMC Cancer|July 29, 2017
Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreasMatthew H G Katz, Fang-Shu Ou, Joseph M Herman, et al.
Current Oncology (Toronto, Ont.)|February 26, 2026
Primary Tumor Size and Tumor-Vessel Interface Following Capecitabine and Temozolomide for Pancreatic Neuroendocrine TumorJin Guo, Kever A Lewis, Laura Prakash, et al.
JAMA Surgery|April 15, 2026
An American College of Surgeons National Quality Improvement Collaborative to Enhance Lung Cancer Surgical QualityKelley Chan, Eileen M Reilly, Ryan C Jacobs, et al.
Journal of the National Cancer Institute|May 11, 2026
Prediction of resection after preoperative FOLFIRINOX in patients with localized pancreatic adenocarcinoma: a Trans-Atlantic Pancreatic Surgery (TAPS) Consortium studyE M M Verkolf, J L van Dam, E N Dekker, et al.
Pageof 75